A COMPARATIVE STUDY OF SAFETY & EFFICACY OF ORAL MISOPROSTOL VERSUS OXYTOCIN IN PREVENTION OF POSTPARTUM HAEMORRHAGE-Reference-Cited by-同舟云学术

A COMPARATIVE STUDY OF SAFETY & EFFICACY OF ORAL MISOPROSTOL VERSUS OXYTOCIN IN PREVENTION OF POSTPARTUM HAEMORRHAGE

Published:2021-08-01 Issue: Volume: Page:73-74
ISSN:
Container-title:INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
language:en
Short-container-title:ijsr

Author:

Maurya Dipali¹,Sharma Anju²,Agrawal Megha³

Affiliation:

1. 3 Year Resident , SMS MC Jaipur

2. Unit Head And Senior Professor , SMS MC Jaipur

3. Associate Professor , SMS MC Jaipur

Abstract

OBJECTIVE: To compare oral misoprostol with intramuscular oxytocin in prevention of postpartum haemorrhage in low risk vaginal birth in a tertiary care centre. METHOD: In a prospective , open label controlled trial, 60 women were randomly allocated to 2 groups. Gr A – 10 units oxytocin i.m Gr B - 600µg misoprostol orally within 1 minute of delivery. The outcome measured was blood loss within 1 hour and 24hrs of delivery. RESULTS: The mean blood loss in 1 hour post delivery was 151.14 ±12.40ml in Group A and 149.82±10.36 ml in Group B. The mean blood loss within 24hrs after delivery was 218.59 ±33.63 ml in Group A and 230.11±31.82 ml in Group B. There was no signicant difference between the groups in terms of blood loss within1 hr and 24 hrs of delivery. CONCLUSION: oral misoprostol 600μg is as effective as intramuscular oxytocin 10IU in the prevention of PPH in low risk vaginal delivery.

Publisher

World Wide Journals

Reference7 articles.

1. Alkema L, Chou D, Hogan D, Zhang S, Moller AB, Gemmil A, et al, Global, Regional and national level and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Interagency Group. 2016; 387(10017) : 462-74.

2. World Health Organization. Recommendations for the prevention of post partum haemorrhage. Geneva:WHO;2007

3. Chaudhuri P, Biswas J, Mandal A. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum haemorrhage in low-risk women. Int J Gynecol Obstet 2012;116:138e42.

4. Peter Wangwe, Hussein Kidanto, Projestine Muganyizi, Jos van Roosmalen. Active management of third stage of labour : misoprostol or oxytocin. African Journal of Midwifery and Women‘s Health, Apr 2009; 3(2): 57-61.

5. Savita Singhal, Nikita Gupta, Kunika Smiti Nanda. Sublingual misoprost versus intramuscular oxytocin in the active management of third stage of labour south Asian federation of obstetrics and gynaecology, 2010;2(3): 199-202